APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Anti-Nausea and Vomiting Healthcare Device

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Anti-Nausea and Vomiting Healthcare Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173965210330 December 2025194 pages

Choose your research edition.

Industry ResearchAnti-Nausea and Vomiting Healthcare Device Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Nausea and Vomiting Healthcare Device Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Anti-Nausea and Vomiting Healthcare Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Nausea and Vomiting Healthcare Device Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Nausea and Vomiting Healthcare Device Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Anti-Nausea and Vomiting Healthcare Device market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Anti-Nausea and Vomiting Healthcare Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anti-Nausea and Vomiting Healthcare Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-Nausea and Vomiting Healthcare Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Anti-Nausea and Vomiting Healthcare Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-Nausea and Vomiting Healthcare Device include Blisslets, Dramamine(Prestige Consumer Healthcare), EmeTerm (WAT Medical), GRAVOL, MotionCure (Sidis Labs), NoMo, Psi Bands, Quease EASE (Soothing Scents) and Reliefband, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anti-Nausea and Vomiting Healthcare Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-Nausea and Vomiting Healthcare Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-Nausea and Vomiting Healthcare Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-Nausea and Vomiting Healthcare Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Anti-Nausea and Vomiting Healthcare Device Segment by Company

Blisslets

Dramamine(Prestige Consumer Healthcare)

EmeTerm (WAT Medical)

GRAVOL

MotionCure (Sidis Labs)

NoMo

Psi Bands

Quease EASE (Soothing Scents)

Reliefband

Sea-Bands

Toulifly

Walgreens

Anti-Nausea and Vomiting Healthcare Device Segment by Type

Inhaler

Wrist Band

Food

Others

Anti-Nausea and Vomiting Healthcare Device Segment by Application

For Children

For Pregnant

For other people with motion sickness

Anti-Nausea and Vomiting Healthcare Device Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Nausea and Vomiting Healthcare Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Nausea and Vomiting Healthcare Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Nausea and Vomiting Healthcare Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anti-Nausea and Vomiting Healthcare Device market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-Nausea and Vomiting Healthcare Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Anti-Nausea and Vomiting Healthcare Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Anti-Nausea and Vomiting Healthcare Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Anti-Nausea and Vomiting Healthcare Device Industry Trends Table 2. Anti-Nausea and Vomiting Healthcare Device Industry Drivers Table 3. Anti-Nausea and Vomiting Healthcare Device Industry Opportunities and Challenges Table 4. Anti-Nausea and Vomiting Healthcare Device Industry Restraints Table 5. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Anti-Nausea and Vomiting Healthcare Device Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Manufacturers Table 9. Global Anti-Nausea and Vomiting Healthcare Device Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Anti-Nausea and Vomiting Healthcare Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Anti-Nausea and Vomiting Healthcare Device Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Anti-Nausea and Vomiting Healthcare Device Manufacturers, Product Type & Application Table 13. Global Anti-Nausea and Vomiting Healthcare Device Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Anti-Nausea and Vomiting Healthcare Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Inhaler Table 17. Major Manufacturers of Wrist Band Table 18. Major Manufacturers of Food Table 19. Major Manufacturers of Others Table 20. Global Anti-Nausea and Vomiting Healthcare Device Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2026) & (K Units) Table 22. Global Anti-Nausea and Vomiting Healthcare Device Sales by Type (2027-2032) & (K Units) Table 23. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Type (2021-2026) Table 24. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Type (2027-2032) Table 25. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2021-2026) & (K Units) Table 27. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2027-2032) & (K Units) Table 28. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Type (2021-2026) Table 29. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of For Children Table 31. Major Manufacturers of For Pregnant Table 32. Major Manufacturers of For other people with motion sickness Table 33. Global Anti-Nausea and Vomiting Healthcare Device Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2026) & (K Units) Table 35. Global Anti-Nausea and Vomiting Healthcare Device Sales by Application (2027-2032) & (K Units) Table 36. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Application (2021-2026) Table 37. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Application (2027-2032) Table 38. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2021-2026) & (K Units) Table 40. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2027-2032) & (K Units) Table 41. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Application (2021-2026) Table 42. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Application (2027-2032) Table 43. Global Anti-Nausea and Vomiting Healthcare Device Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Anti-Nausea and Vomiting Healthcare Device Sales by Region (2021-2026) & (K Units) Table 45. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Region (2021-2026) Table 46. Global Anti-Nausea and Vomiting Healthcare Device Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Anti-Nausea and Vomiting Healthcare Device Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Anti-Nausea and Vomiting Healthcare Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2026) & (K Units) Table 50. North America Anti-Nausea and Vomiting Healthcare Device Sales by Country (2027-2032) & (K Units) Table 51. Europe Anti-Nausea and Vomiting Healthcare Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2026) & (K Units) Table 53. Europe Anti-Nausea and Vomiting Healthcare Device Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Anti-Nausea and Vomiting Healthcare Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Anti-Nausea and Vomiting Healthcare Device Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales by Country (2027-2032) & (K Units) Table 60. Global Anti-Nausea and Vomiting Healthcare Device Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Region (2021-2026) Table 64. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Region (2027-2032) Table 65. Blisslets Company Information Table 66. Blisslets Business Overview Table 67. Blisslets Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Blisslets Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 69. Blisslets Recent Development Table 70. Dramamine(Prestige Consumer Healthcare) Company Information Table 71. Dramamine(Prestige Consumer Healthcare) Business Overview Table 72. Dramamine(Prestige Consumer Healthcare) Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Dramamine(Prestige Consumer Healthcare) Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 74. Dramamine(Prestige Consumer Healthcare) Recent Development Table 75. EmeTerm (WAT Medical) Company Information Table 76. EmeTerm (WAT Medical) Business Overview Table 77. EmeTerm (WAT Medical) Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. EmeTerm (WAT Medical) Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 79. EmeTerm (WAT Medical) Recent Development Table 80. GRAVOL Company Information Table 81. GRAVOL Business Overview Table 82. GRAVOL Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. GRAVOL Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 84. GRAVOL Recent Development Table 85. MotionCure (Sidis Labs) Company Information Table 86. MotionCure (Sidis Labs) Business Overview Table 87. MotionCure (Sidis Labs) Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. MotionCure (Sidis Labs) Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 89. MotionCure (Sidis Labs) Recent Development Table 90. NoMo Company Information Table 91. NoMo Business Overview Table 92. NoMo Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. NoMo Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 94. NoMo Recent Development Table 95. Psi Bands Company Information Table 96. Psi Bands Business Overview Table 97. Psi Bands Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Psi Bands Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 99. Psi Bands Recent Development Table 100. Quease EASE (Soothing Scents) Company Information Table 101. Quease EASE (Soothing Scents) Business Overview Table 102. Quease EASE (Soothing Scents) Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Quease EASE (Soothing Scents) Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 104. Quease EASE (Soothing Scents) Recent Development Table 105. Reliefband Company Information Table 106. Reliefband Business Overview Table 107. Reliefband Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Reliefband Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 109. Reliefband Recent Development Table 110. Sea-Bands Company Information Table 111. Sea-Bands Business Overview Table 112. Sea-Bands Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Sea-Bands Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 114. Sea-Bands Recent Development Table 115. Toulifly Company Information Table 116. Toulifly Business Overview Table 117. Toulifly Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Toulifly Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 119. Toulifly Recent Development Table 120. Walgreens Company Information Table 121. Walgreens Business Overview Table 122. Walgreens Anti-Nausea and Vomiting Healthcare Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Walgreens Anti-Nausea and Vomiting Healthcare Device Product Portfolio Table 124. Walgreens Recent Development Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. Anti-Nausea and Vomiting Healthcare Device Distributors List Table 128. Anti-Nausea and Vomiting Healthcare Device Customers List Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Anti-Nausea and Vomiting Healthcare Device Product Image Figure 2. Global Anti-Nausea and Vomiting Healthcare Device Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Nausea and Vomiting Healthcare Device Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-Nausea and Vomiting Healthcare Device Sales (2021-2032) & (K Units) Figure 5. Global Anti-Nausea and Vomiting Healthcare Device Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Anti-Nausea and Vomiting Healthcare Device Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Inhaler Image Figure 9. Wrist Band Image Figure 10. Food Image Figure 11. Others Image Figure 12. Global Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Type (2021-2032) Figure 15. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Type (2021-2032) Figure 18. For Children Image Figure 19. For Pregnant Image Figure 20. For other people with motion sickness Image Figure 21. Global Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Application (2021-2032) Figure 24. Global Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Application (2021-2032) Figure 27. North America Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Country (2021-2032) Figure 29. U.S. Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Country (2021-2032) Figure 34. Germany Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Country (2021-2032) Figure 41. China Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Country (2021-2032) Figure 49. Brazil Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Anti-Nausea and Vomiting Healthcare Device Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Anti-Nausea and Vomiting Healthcare Device Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Figure 60. North America Anti-Nausea and Vomiting Healthcare Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Figure 62. Europe Anti-Nausea and Vomiting Healthcare Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Anti-Nausea and Vomiting Healthcare Device Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Anti-Nausea and Vomiting Healthcare Device Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Inhaler
  • Wrist Band
  • Food
  • Others
Applications
  • For Children
  • For Pregnant
  • For other people with motion sickness
Companies covered
  • Blisslets
  • Dramamine(Prestige Consumer Healthcare)
  • EmeTerm (WAT Medical)
  • GRAVOL
  • MotionCure (Sidis Labs)
  • NoMo
  • Psi Bands
  • Quease EASE (Soothing Scents)
  • Reliefband
  • Sea-Bands
  • Toulifly
  • Walgreens

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Anti-Nausea and Vomiting Healthcare Device Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Anti-Nausea and Vomiting Healthcare Device Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Anti-Nausea and Vomiting Healthcare Device Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Anti-Nausea and Vomiting Healthcare Device Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Anti-Nausea and Vomiting Healthcare Device Market Dynamics
  1. 2.1 Anti-Nausea and Vomiting Healthcare Device Industry Trends
  2. 2.2 Anti-Nausea and Vomiting Healthcare Device Industry Drivers
  3. 2.3 Anti-Nausea and Vomiting Healthcare Device Industry Opportunities and Challenges
  4. 2.4 Anti-Nausea and Vomiting Healthcare Device Industry Restraints
3 Anti-Nausea and Vomiting Healthcare Device Market by Manufacturers
  1. 3.1 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Anti-Nausea and Vomiting Healthcare Device Sales by Manufacturers (2021-2026)
  3. 3.3 Global Anti-Nausea and Vomiting Healthcare Device Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Anti-Nausea and Vomiting Healthcare Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-Nausea and Vomiting Healthcare Device Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Anti-Nausea and Vomiting Healthcare Device Manufacturers, Product Type & Application
  7. 3.7 Global Anti-Nausea and Vomiting Healthcare Device Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-Nausea and Vomiting Healthcare Device Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-Nausea and Vomiting Healthcare Device Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-Nausea and Vomiting Healthcare Device Tier 1, Tier 2, and Tier 3
4 Anti-Nausea and Vomiting Healthcare Device Market by Type
  1. 4.1 Anti-Nausea and Vomiting Healthcare Device Type Introduction
  2. 4.1.1 Inhaler
  3. 4.1.2 Wrist Band
  4. 4.1.3 Food
  5. 4.1.4 Others
  6. 4.2 Global Anti-Nausea and Vomiting Healthcare Device Sales by Type
  7. 4.2.1 Global Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2032)
  9. 4.2.3 Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Type (2021-2032)
  10. 4.3 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Type
  11. 4.3.1 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2021-2032)
  13. 4.3.3 Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Type (2021-2032)
5 Anti-Nausea and Vomiting Healthcare Device Market by Application
  1. 5.1 Anti-Nausea and Vomiting Healthcare Device Application Introduction
  2. 5.1.1 For Children
  3. 5.1.2 For Pregnant
  4. 5.1.3 For other people with motion sickness
  5. 5.2 Global Anti-Nausea and Vomiting Healthcare Device Sales by Application
  6. 5.2.1 Global Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2032)
  8. 5.2.3 Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Application (2021-2032)
  9. 5.3 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Application
  10. 5.3.1 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2021-2032)
  12. 5.3.3 Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Application (2021-2032)
6 Global Anti-Nausea and Vomiting Healthcare Device Sales by Region
  1. 6.1 Global Anti-Nausea and Vomiting Healthcare Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anti-Nausea and Vomiting Healthcare Device Sales by Region (2021-2032)
  3. 6.2.1 Global Anti-Nausea and Vomiting Healthcare Device Sales by Region (2021-2026)
  4. 6.2.2 Global Anti-Nausea and Vomiting Healthcare Device Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Anti-Nausea and Vomiting Healthcare Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Anti-Nausea and Vomiting Healthcare Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Anti-Nausea and Vomiting Healthcare Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Region
  1. 7.1 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Region
  2. 7.1.1 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Region (2021-2026)
  4. 7.1.3 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Region (2027-2032)
  5. 7.1.4 Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032)
  8. 7.2.2 North America Anti-Nausea and Vomiting Healthcare Device Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032)
  11. 7.3.2 Europe Anti-Nausea and Vomiting Healthcare Device Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Anti-Nausea and Vomiting Healthcare Device Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Blisslets
  2. 8.1.1 Blisslets Company Information
  3. 8.1.2 Blisslets Business Overview
  4. 8.1.3 Blisslets Anti-Nausea and Vomiting Healthcare Device Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Blisslets Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  6. 8.1.5 Blisslets Recent Developments
  7. 8.2 Dramamine(Prestige Consumer Healthcare)
  8. 8.2.1 Dramamine(Prestige Consumer Healthcare) Company Information
  9. 8.2.2 Dramamine(Prestige Consumer Healthcare) Business Overview
  10. 8.2.3 Dramamine(Prestige Consumer Healthcare) Anti-Nausea and Vomiting Healthcare Device Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Dramamine(Prestige Consumer Healthcare) Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  12. 8.2.5 Dramamine(Prestige Consumer Healthcare) Recent Developments
  13. 8.3 EmeTerm (WAT Medical)
  14. 8.3.1 EmeTerm (WAT Medical) Company Information
  15. 8.3.2 EmeTerm (WAT Medical) Business Overview
  16. 8.3.3 EmeTerm (WAT Medical) Anti-Nausea and Vomiting Healthcare Device Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 EmeTerm (WAT Medical) Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  18. 8.3.5 EmeTerm (WAT Medical) Recent Developments
  19. 8.4 GRAVOL
  20. 8.4.1 GRAVOL Company Information
  21. 8.4.2 GRAVOL Business Overview
  22. 8.4.3 GRAVOL Anti-Nausea and Vomiting Healthcare Device Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GRAVOL Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  24. 8.4.5 GRAVOL Recent Developments
  25. 8.5 MotionCure (Sidis Labs)
  26. 8.5.1 MotionCure (Sidis Labs) Company Information
  27. 8.5.2 MotionCure (Sidis Labs) Business Overview
  28. 8.5.3 MotionCure (Sidis Labs) Anti-Nausea and Vomiting Healthcare Device Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 MotionCure (Sidis Labs) Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  30. 8.5.5 MotionCure (Sidis Labs) Recent Developments
  31. 8.6 NoMo
  32. 8.6.1 NoMo Company Information
  33. 8.6.2 NoMo Business Overview
  34. 8.6.3 NoMo Anti-Nausea and Vomiting Healthcare Device Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 NoMo Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  36. 8.6.5 NoMo Recent Developments
  37. 8.7 Psi Bands
  38. 8.7.1 Psi Bands Company Information
  39. 8.7.2 Psi Bands Business Overview
  40. 8.7.3 Psi Bands Anti-Nausea and Vomiting Healthcare Device Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Psi Bands Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  42. 8.7.5 Psi Bands Recent Developments
  43. 8.8 Quease EASE (Soothing Scents)
  44. 8.8.1 Quease EASE (Soothing Scents) Company Information
  45. 8.8.2 Quease EASE (Soothing Scents) Business Overview
  46. 8.8.3 Quease EASE (Soothing Scents) Anti-Nausea and Vomiting Healthcare Device Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Quease EASE (Soothing Scents) Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  48. 8.8.5 Quease EASE (Soothing Scents) Recent Developments
  49. 8.9 Reliefband
  50. 8.9.1 Reliefband Company Information
  51. 8.9.2 Reliefband Business Overview
  52. 8.9.3 Reliefband Anti-Nausea and Vomiting Healthcare Device Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Reliefband Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  54. 8.9.5 Reliefband Recent Developments
  55. 8.10 Sea-Bands
  56. 8.10.1 Sea-Bands Company Information
  57. 8.10.2 Sea-Bands Business Overview
  58. 8.10.3 Sea-Bands Anti-Nausea and Vomiting Healthcare Device Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sea-Bands Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  60. 8.10.5 Sea-Bands Recent Developments
  61. 8.11 Toulifly
  62. 8.11.1 Toulifly Company Information
  63. 8.11.2 Toulifly Business Overview
  64. 8.11.3 Toulifly Anti-Nausea and Vomiting Healthcare Device Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Toulifly Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  66. 8.11.5 Toulifly Recent Developments
  67. 8.12 Walgreens
  68. 8.12.1 Walgreens Company Information
  69. 8.12.2 Walgreens Business Overview
  70. 8.12.3 Walgreens Anti-Nausea and Vomiting Healthcare Device Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Walgreens Anti-Nausea and Vomiting Healthcare Device Product Portfolio
  72. 8.12.5 Walgreens Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anti-Nausea and Vomiting Healthcare Device Value Chain Analysis
  2. 9.1.1 Anti-Nausea and Vomiting Healthcare Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anti-Nausea and Vomiting Healthcare Device Production Mode & Process
  6. 9.2 Anti-Nausea and Vomiting Healthcare Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anti-Nausea and Vomiting Healthcare Device Distributors
  9. 9.2.3 Anti-Nausea and Vomiting Healthcare Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst